Mitoxantrone 2 mg/ml concentrate for solution for infusion

DRUG3 trials

Sponsors

Prinses Maxima Centrum voor Kinderoncologie B.V., Charite Universitaetsmedizin Berlin KöR

Conditions

Acute Myeloid LeukemiaRelapsed Acute Lymphoblastic Leukemia (ALL)

Phase 2

International Study for Treatment of High Risk Childhood Relapsed ALL 2010 - A randomized Phase II Study Conducted by the Resistant Disease Committee of the International BFM Study Group – IntReALL HR 2010

Active, not recruitingCTIS2024-513070-21-00

Charite Universitaetsmedizin Berlin KöRRelapsed Acute Lymphoblastic Leukemia (ALL)

Start: 2018-02-15Target: 222Updated: 2025-09-17

Phase 3

CHIP-AML22 Master protocol: An open label complex clinical trial in newly diagnosed pediatric de novo AML patients – a study by the NOPHO-DB-SHIP consortium Master Protocol

RecruitingCTIS2023-504999-25-00

Prinses Maxima Centrum voor Kinderoncologie B.V.Acute Myeloid Leukemia

Start: 2023-07-14Target: 675Updated: 2025-08-14

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020

Not yet recruitingCTIS2023-509392-17-00

Charite Universitaetsmedizin Berlin KöRRelapsed Acute Lymphoblastic Leukemia (ALL)

Target: 765Updated: 2025-12-15